Medication info
Dipyrilem Tablet 2/500 mg

Dipyrilem Tablet 2/500 mg

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tabletGlimepiride›2mg / 1 tablet
Manufacturer / importer
Hwanin Pharmaceutical Co., Ltd.
Appearance
White rectangular film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201107002 · Approved 2011.09.23

Summary

Main use
Improves glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Administer this medicine 1 to 2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, and the dose may be adjusted considering the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and there was experience with gradually increasing the dose according to blood glucose monitoring results, up to glimepiride/metformin hydrochloride 8mg/2000mg. As a single agent, glimepiride generally provides little additional benefit at doses above 4mg per day, although some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer based on the dosage and administration of the glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than one dose at the next scheduled administration.

Ingredients

Manufacturer
Hwanin Pharmaceutical Co., Ltd.

Efficacy & effects

Improves glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication is prescribed to assist in blood sugar control in patients with type 2 diabetes using a combination of Glimepiride and Metformin. When taken alongside dietary and exercise regimens, it can effectively manage blood sugar levels. This helps to improve blood sugar control capabilities, aiding in diabetes treatment.

How to take

Adult dose

Administer this medicine 1 to 2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, and the dose may be adjusted considering the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and there was experience with gradually increasing the dose according to blood glucose monitoring results, up to glimepiride/metformin hydrochloride 8mg/2000mg. As a single agent, glimepiride generally provides little additional benefit at doses above 4mg per day, although some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer based on the dosage and administration of the glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than one dose at the next scheduled administration.

Precautions

This medication can cause severe lactic acidosis or hypoglycemia; therefore, if there is a rapid deterioration in kidney function or signs of dehydration, usage should be temporarily suspended, and a doctor should be consulted. Additionally, there may be an increased risk of cardiovascular disease, so attention to heart health is necessary while taking this medication. Patients with insulin-dependent diabetes, acute metabolic acidosis, severe liver or kidney impairment, and women who are pregnant or breastfeeding should not take this medication. Particular attention is needed for the elderly, malnourished individuals, those with irregular eating habits, and excessive alcohol consumption regarding the risk of hypoglycemia, and immediate action should be taken if hypoglycemic symptoms occur. Initially, gastrointestinal symptoms (diarrhea, nausea, vomiting, etc.) may appear, but these are generally temporary and can be alleviated by taking the medication with meals. This medication may decrease vitamin B12 levels; therefore, regular monitoring of vitamin B12 concentration is advisable during long-term use. Drug interactions may occur, so if there are other medications being taken, it is essential to inform the doctor or pharmacist. Women who are pregnant or planning to become pregnant should receive insulin therapy instead of this medication for safety. In case of overdose, hypoglycemia and lactic acidosis may occur; hence, do not change or discontinue your dosage without a doctor's advice and consult medical personnel immediately if any unusual symptoms appear. Be cautious of potential accidents due to hypoglycemia or reduced agility when driving or operating machinery. Keep out of the reach of children and do not transfer to other containers.

Side effects

  • Lactic acidosis
  • hypoglycemia
  • diarrhea
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • indigestion
  • constipation
  • abdominal pain
Show 73 more
  • unpleasant metallic taste
  • visual impairment
  • taste disorder
  • erythema
  • itching
  • hives
  • rash
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • anemia
  • agranulocytosis
  • pancytopenia
  • decreased vitamin B12
  • peripheral neuropathy
  • megaloblastic anemia
  • increased liver enzymes
  • liver function impairment
  • cholestasis
  • jaundice
  • hepatitis
  • allergic vasculitis
  • photosensitivity
  • decreased serum sodium concentration
  • hypothyroidism
  • magnesium deficiency in diarrhea
  • encephalopathy
  • hair loss
  • weight gain
  • abdominal pain
  • abdominal distension
  • vomiting
  • indigestion
  • palpitations
  • dizziness
  • diarrhea
  • nausea
  • leg edema
  • cardiac arrest
  • rectal carcinoma
  • hypoglycemia
  • headache
  • severe hunger
  • fatigue
  • sleep disorder
  • instability
  • aggression
  • attention deficit
  • inability to concentrate
  • abnormal reactions
  • depression
  • confusion
  • language disorder
  • aphasia
  • tremor
  • paralysis
  • sensory disturbance
  • dizziness
  • inability to self-regulate
  • delirium
  • cerebral seizures
  • loss of consciousness
  • coma
  • weak respiration
  • slow pulse
  • sweating
  • clammy skin
  • anxiety
  • rapid pulse
  • hypertension
  • palpitations
  • angina
  • deep vein thrombosis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, ideally at room temperature between 1°C and 30°C. Proper storage helps maintain the effectiveness of the medication and prevents deterioration.

Appearance and packaging

Appearance

White rectangular film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.